Article Details

Novo's Wegovy becomes first GLP-1 drug approved for MASH | BioPharma Dive

Retrieved on: 2025-08-18 13:04:37

Tags for this article:

Click the tags to see associated articles and topics

Novo's Wegovy becomes first GLP-1 drug approved for MASH | BioPharma Dive. View article details on hiswai:

Excerpt

The FDA clearance sets Novo's medicine up a market battle with Madrigal Pharmaceuticals' fast-selling Rezdiffra.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo